DOP046. Mid- to long-term stability and associated prognostic factors of adalimumab treatment for 1 189 patients with Crohn’s disease: a multicentre cohort study | Zendy

AI Assistant Blog Pricing

DOP046. Mid- to long-term stability and associated prognostic factors of adalimumab treatment for 1 189 patients with Crohn’s disease: a multicentre cohort study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.